Abstract:Objective Valproic acid(VPA) is an established drug in the long-term therapy of seizure disorders.Recently,VPA has been associated with anticancer activity,an effect thought to be produced by inhibition of cellular histone deacetylase 1.Methods The PC3 cell line tumor xenografts was established.Animals in the experimental group were given 0.4% VPA in their drinking water until tumors reached 5 mm in the longest dimension.At the end of day 28,tumors were harvested,whole blood was collected and serum was analyzed for VPA,liver function tests(transaminases) and complete blood count.The DNA strand breaks were identified by the terminal deoxynucleotidyltransferase-mediated UTP end labeling technique using the in situ Cell Death Detection Kit.Effects of VPA on histone acetylation and p21WAF/CIP gene expression were investigated by Western blot.Ki67 and p21WAF/CIP were detected by Immunohistochemistry in tissues of PC3 cell line tumor xenografts.Results Chronic VPA treatment resulted in statistically significant reduction of tumor xenograft growth in vivo.Tumor volumes were measured and compared using the Wilcoxon rank-sum test and 2-way ANOVA with post-hoc testing.Animals treated with VPA showed a statistically significant decrease in tumor volume compared with controls with 77.27% growth inhibition.Treatment of xenografts with VPA induced a significant increase in levels of acetylated histone H3 and p21WAF/CIP compared with the controls(P<0.01).In the VPA treated tumors,apoptotic cell death was markedly increased compared with the control tumors (P<0.01).Ki67 expression in the control group was stronger than in the experimental group(P<0.01).Conclusion We conclude that chronic administration of VPA results in a significant reduction in PC3 cell line tumor xenograft volume in vivo.These data provide compelling evidence that additional studies are warranted in evaluating the potential use of chronic VPA as a means of alteringandrogen independent prostate cancer cell growth and progression.

Antitumor activity of sodium valproate in cultures of human neuroblastoma cells

Valproic Acid Suppresses Warburg Effect and Tumor Progression in Neuroblastoma.

Valproic acid inhibits the proliferation of SHSY5Y neuroblastoma cancer cells by downregulating URG4/URGCP and CCND1 gene expression

Cytotoxic Effects of Valproic Acid on Neuroendocrine Tumour Cells

Sodium valproate inhibits proliferation in rat neural stem cells through p21 pathway

Modulation of Stemness and Differentiation Regulators by Valproic Acid in Medulloblastoma

Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC

Valproic acid inhibits the growth of cervical cancer both in vitro and in vivo.

Inhibition of Proliferation and Induction of Apoptosis and Differentiation of Leukemic Cell Line HL-60 by Sodium Valproate

Long-term use of Valproic acid inhibits the PC3 cell line growth in nude mice in vivo

Effects of Sodium Valproate on Proliferation and Apoptosis of Chronic Myeloid Leukemia Cell Line K562

Valproate and valproate-analogues: potent tools to fight against cancer

The Neurotrophin Receptor TrkC as a Novel Molecular Target of the Antineuroblastoma Action of Valproic Acid

Analyzing the Molecular Mechanisms in Sodium Valproate-Induced Differentiation of NB4 Cells Using Microarray Combined with the MAS Tool

Novel valproic acid derivatives with potent differentiation-inducing activity in myeloid leukemia cells

Valproic acid suppresses cervical cancer tumor progression possibly via activating Notch1 signaling and enhances receptor-targeted cancer chemotherapeutic via activating somatostatin receptor type II

[Effects of Sodium Valproate on Proliferation and Apoptosis of Human Myelodysplastic Syndromes Cell Line MUTZ-1].

Anticancer Effects of Valproic Acid on Oral Squamous Cell Carcinoma Via Sumoylation in Vivo and in Vitro

The therapeutic and neuroprotective effects of an antiepileptic drug valproic acid in glioma patients.

Valproic Acid Promotes Human Glioma U87 Cells Apoptosis and Inhibits Glycogen Synthase Kinase-3β Through ERK/Akt Signaling.

Sodium valproate affects the expression of p16 INK4a and p21 WAFI/Cip1 cyclin‐dependent kinase inhibitors in HeLa cells